550 related articles for article (PubMed ID: 31126323)
1. Targeted ablation of the cellular inhibitor of apoptosis 1 (cIAP1) attenuates denervation-induced skeletal muscle atrophy.
Lala-Tabbert N; Lejmi-Mrad R; Timusk K; Fukano M; Holbrook J; St-Jean M; LaCasse EC; Korneluk RG
Skelet Muscle; 2019 May; 9(1):13. PubMed ID: 31126323
[TBL] [Abstract][Full Text] [Related]
2. PHD3 mediates denervation skeletal muscle atrophy through Nf-κB signal pathway.
Li F; Yin C; Ma Z; Yang K; Sun L; Duan C; Wang T; Hussein A; Wang L; Zhu X; Gao P; Xi Q; Zhang Y; Shu G; Wang S; Jiang Q
FASEB J; 2021 Apr; 35(4):e21444. PubMed ID: 33749901
[TBL] [Abstract][Full Text] [Related]
3. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
4. Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1.
He Z; Song Q; Yu Y; Liu F; Zhao J; Un W; Da X; Xu C; Yao Y; Wang QK
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):978-991. PubMed ID: 36696895
[TBL] [Abstract][Full Text] [Related]
5. Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.
Paul PK; Gupta SK; Bhatnagar S; Panguluri SK; Darnay BG; Choi Y; Kumar A
J Cell Biol; 2010 Dec; 191(7):1395-411. PubMed ID: 21187332
[TBL] [Abstract][Full Text] [Related]
6. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
7. TWEAK and cIAP1 regulate myoblast fusion through the noncanonical NF-κB signaling pathway.
Enwere EK; Holbrook J; Lejmi-Mrad R; Vineham J; Timusk K; Sivaraj B; Isaac M; Uehling D; Al-awar R; LaCasse E; Korneluk RG
Sci Signal; 2012 Oct; 5(246):ra75. PubMed ID: 23074266
[TBL] [Abstract][Full Text] [Related]
8. Absence of caspase-3 protects against denervation-induced skeletal muscle atrophy.
Plant PJ; Bain JR; Correa JE; Woo M; Batt J
J Appl Physiol (1985); 2009 Jul; 107(1):224-34. PubMed ID: 19390003
[TBL] [Abstract][Full Text] [Related]
9. Denervation drives skeletal muscle atrophy and induces mitochondrial dysfunction, mitophagy and apoptosis via miR-142a-5p/MFN1 axis.
Yang X; Xue P; Chen H; Yuan M; Kang Y; Duscher D; Machens HG; Chen Z
Theranostics; 2020; 10(3):1415-1432. PubMed ID: 31938072
[No Abstract] [Full Text] [Related]
10. MyD88-mediated signaling intercedes in neurogenic muscle atrophy through multiple mechanisms.
Parveen A; Bohnert KR; Tomaz da Silva M; Wen Y; Bhat R; Roy A; Kumar A
FASEB J; 2021 Aug; 35(8):e21821. PubMed ID: 34325487
[TBL] [Abstract][Full Text] [Related]
11. The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.
Mittal A; Bhatnagar S; Kumar A; Lach-Trifilieff E; Wauters S; Li H; Makonchuk DY; Glass DJ; Kumar A
J Cell Biol; 2010 Mar; 188(6):833-49. PubMed ID: 20308426
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids increase skeletal muscle NF-κB inducing kinase (NIK): links to muscle atrophy.
Fry CS; Nayeem SZ; Dillon EL; Sarkar PS; Tumurbaatar B; Urban RJ; Wright TJ; Sheffield-Moore M; Tilton RG; Choudhary S
Physiol Rep; 2016 Nov; 4(21):. PubMed ID: 27905294
[TBL] [Abstract][Full Text] [Related]
13. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
14. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice.
Cai D; Frantz JD; Tawa NE; Melendez PA; Oh BC; Lidov HG; Hasselgren PO; Frontera WR; Lee J; Glass DJ; Shoelson SE
Cell; 2004 Oct; 119(2):285-98. PubMed ID: 15479644
[TBL] [Abstract][Full Text] [Related]
15. Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia.
Bowen TS; Adams V; Werner S; Fischer T; Vinke P; Brogger MN; Mangner N; Linke A; Sehr P; Lewis J; Labeit D; Gasch A; Labeit S
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):939-953. PubMed ID: 28887874
[TBL] [Abstract][Full Text] [Related]
16. Heightened TWEAK-NF-κB signaling and inflammation-associated fibrosis in paralyzed muscles of men with chronic spinal cord injury.
Yarar-Fisher C; Bickel CS; Kelly NA; Stec MJ; Windham ST; McLain AB; Oster RA; Bamman MM
Am J Physiol Endocrinol Metab; 2016 May; 310(9):E754-61. PubMed ID: 26931128
[TBL] [Abstract][Full Text] [Related]
17. Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss.
Jin B; Li YP
J Cell Biochem; 2007 Mar; 100(4):960-9. PubMed ID: 17131360
[TBL] [Abstract][Full Text] [Related]
18. Maslinic Acid Attenuates Denervation-Induced Loss of Skeletal Muscle Mass and Strength.
Yamauchi Y; Ferdousi F; Fukumitsu S; Isoda H
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578826
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol attenuates skeletal muscle atrophy induced by chronic kidney disease via MuRF1 signaling pathway.
Sun LJ; Sun YN; Chen SJ; Liu S; Jiang GR
Biochem Biophys Res Commun; 2017 May; 487(1):83-89. PubMed ID: 28392400
[TBL] [Abstract][Full Text] [Related]
20. Heat shock protein 70 overexpression does not attenuate atrophy in botulinum neurotoxin type A-treated skeletal muscle.
Houston FE; Hain BA; Adams TJ; Houston KL; O'Keeffe R; Dodd SL
J Appl Physiol (1985); 2015 Jul; 119(1):83-92. PubMed ID: 25953835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
